Provided herein are methods, kits and compositions for the treatment and/or prevention of ovarian cancer through the induction of an immune response against Anti-Mullerian Hormone Receptor, Type II (AMHR2).
申请公布号
WO2017040969(A1)
申请公布日期
2017.03.09
申请号
WO2016US50159
申请日期
2016.09.02
申请人
THE CLEVELAND CLINIC FOUNDATION
发明人
TUOHY, Vincent, K.;MAZUMDER, Suparna;JOHNSON, Justin, M.
